In Arizona, Axolotl Biologix, a regenerative human cell and tissue medical technologies company, entered into an exclusive worldwide license agreement with Protein Genomics, Inc., an R&D company focused on biopolymers for applications in wound healing and tissue regeneration. The license agreement allows Axolotl Biologix to use Protein Genomics’ patents and manufacturing knowledge for a biomimetic skin substitute made from biomaterial called Elastropin. This will help grow and expand Axolotl Biologix’s burn, surgical and wound treatment products. Axolotl Biologix is also acquiring Protein Genomics’ research laboratory in Flagstaff as part of the agreement, and gave a heads up that they plan on filing three new patents in the very near future, so stay tuned.
Home Biomaterials Axolotl Biologix Acquires Protein Genomics’ Research Lab and Signs License Agreement
Latest article
Bioplastic straws an unlikely savior for coral
In Florida, researchers have developed a novel solution to keeping young, vulnerable coral from being eaten by predatory fish: protective cages made from bioplastic...
Canadian rapper Drake photographed sporting biobased EVA slip ons from Kane
In Canada, “Hotline Bling” rapper Drake has been seen sporting pink biobased slip-on shoes designed by Kane.
Founded in 2020 by former Maverik Lacrosse CEO...
Sorry parents, fruit waste glitter is still a pain to clean up
In the United Kingdom, scientists at Cambridge University have developed biodegradable glitter made from nanocrystals of cellulose extracted from fruit waste.
The sustainable sparkle solution...